Non-surgical treatment of Granulomatous Mastitis

Comparison of the effects of three types of non-surgical treatments in the management of idiopathic Granulomatous Mastitis

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20100706004329N10

Enrollment

147

Registered

2021-05-07

Start date

2021-05-22

Completion date

Unknown

Last updated

2021-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic Granulomatous mastitis. Inflammatory disorders of breast

Interventions

Intervention 1: Intervention group 1: They will take Prednisolone 15 mg daily, and in case of treatment refractory, they will take Prednisolone at a dose of 30 mg. Intervention 2: Intervention group

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Pathological diagnosis of Granulomatous Mastitis

Exclusion criteria

Exclusion criteria: Fungal infection Tuberculosis Systemic symptoms including fever (not due to super infection of Granulomatous Mastitis) Polyarthritis or Polyarthralgia Generalized lymphadenopathy

Design outcomes

Primary

Measure	Time frame
Ulcer. Timepoint: Before the intervention and then every three weeks to three months. Method of measurement: Examination.;Fistula. Timepoint: Before the intervention and then every three weeks to three months. Method of measurement: Examination.;Size of Erythema. Timepoint: Before the intervention and then every three weeks to three months. Method of measurement: Examination.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSadaf Alipour

Tehran University of Medical Sciences

salipour@sina.tums.ac.ir+98 21 7771 9922

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026